• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大多数 Cochrane 综述的选择性报告风险评估不充分。

Risk of bias assessments for selective reporting were inadequate in the majority of Cochrane reviews.

机构信息

Department of Radiology, University Hospital Split, Split, Croatia.

Department of Surgery, University Hospital Split, Split, Croatia.

出版信息

J Clin Epidemiol. 2019 Aug;112:53-58. doi: 10.1016/j.jclinepi.2019.04.007. Epub 2019 Apr 19.

DOI:10.1016/j.jclinepi.2019.04.007
PMID:31009658
Abstract

OBJECTIVES

The aim of the study was to analyze adequacy of risk of bias (RoB) judgments for selective reporting in Cochrane systematic reviews.

STUDY DESIGN AND SETTING

We extracted RoB assessments, including judgment (low, high, or unclear risk) and supporting comment from Cochrane reviews of randomized controlled trials using computer parser. We analyzed sources of information mentioned in supporting comments. We compared judgments of Cochrane authors with guidance from the Cochrane Handbook for Systematic Reviews of Interventions (Cochrane Handbook) and categorized them into adequate or inadequate.

RESULTS

At least 60% of judgments for risk of selective reporting bias of trials in analyzed Cochrane reviews were not in line with the Cochrane Handbook. Few Cochrane authors mentioned the trial protocol as a source of data for assessing selective reporting. Most of the inadequate judgments were made among trials that were judged with low risk of selective reporting bias; more than 90%. In 9% of analyzed RoB tables, Cochrane authors did not use this RoB domain at all.

CONCLUSION

Cochrane authors frequently make RoB judgments about selective reporting that are not in line with Cochrane Handbook and not mentioning trial protocol. Interventions aimed at helping Cochrane authors to make adequate RoB assessments in Cochrane reviews would be beneficial.

摘要

目的

本研究旨在分析 Cochrane 系统评价中选择性报告风险偏倚(RoB)判断的充分性。

研究设计与设置

我们使用计算机解析器从 Cochrane 随机对照试验的系统评价中提取 RoB 评估,包括判断(低、高或不明确风险)和支持性评论。我们分析了支持性评论中提到的信息来源。我们将 Cochrane 作者的判断与干预 Cochrane 系统评价手册(Cochrane Handbook)的指导进行比较,并将其归类为充分或不充分。

结果

在分析的 Cochrane 综述中,至少有 60%的试验选择性报告偏倚风险的判断与 Cochrane 手册不一致。少数 Cochrane 作者提到试验方案是评估选择性报告的数据源。大多数不充分的判断是在被判断为选择性报告偏倚风险低的试验中做出的;超过 90%。在 9%的分析 RoB 表中,Cochrane 作者根本没有使用这个 RoB 领域。

结论

Cochrane 作者经常对选择性报告做出与 Cochrane 手册不一致的 RoB 判断,并且不提及试验方案。旨在帮助 Cochrane 作者在 Cochrane 综述中进行充分 RoB 评估的干预措施将是有益的。

相似文献

1
Risk of bias assessments for selective reporting were inadequate in the majority of Cochrane reviews.大多数 Cochrane 综述的选择性报告风险评估不充分。
J Clin Epidemiol. 2019 Aug;112:53-58. doi: 10.1016/j.jclinepi.2019.04.007. Epub 2019 Apr 19.
2
Risk of bias judgments for random sequence generation in Cochrane systematic reviews were frequently not in line with Cochrane Handbook.Cochrane 系统评价中随机序列生成的偏倚风险判断常常与 Cochrane 手册不一致。
BMC Med Res Methodol. 2019 Aug 5;19(1):170. doi: 10.1186/s12874-019-0804-y.
3
In Cochrane reviews, risk of bias assessments for allocation concealment were frequently not in line with Cochrane's Handbook guidance.在 Cochrane 综述中,分配隐藏的偏倚风险评估经常不符合 Cochrane 手册指南。
J Clin Epidemiol. 2019 Feb;106:10-17. doi: 10.1016/j.jclinepi.2018.10.002. Epub 2018 Oct 9.
4
Cochrane risk of bias tool was used inadequately in the majority of non-Cochrane systematic reviews.Cochrane 偏倚风险工具在大多数非 Cochrane 系统评价中使用不当。
J Clin Epidemiol. 2020 Jul;123:114-119. doi: 10.1016/j.jclinepi.2020.03.019. Epub 2020 Apr 1.
5
Risk of bias assessments for blinding of participants and personnel in Cochrane reviews were frequently inadequate.Cochrane 综述中对参与者和人员进行盲法评估的风险常常不够充分。
J Clin Epidemiol. 2019 Sep;113:104-113. doi: 10.1016/j.jclinepi.2019.05.012. Epub 2019 May 24.
6
Adequacy of risk of bias assessment in surgical vs non-surgical trials in Cochrane reviews: a methodological study.Cochrane 综述中手术与非手术试验的偏倚风险评估充分性:一项方法学研究。
BMC Med Res Methodol. 2020 Sep 29;20(1):240. doi: 10.1186/s12874-020-01123-7.
7
The judgement of biases included in the category "other bias" in Cochrane systematic reviews of interventions: a systematic survey.Cochrane 系统评价干预措施中“其他偏倚”类别中偏倚的判断:系统调查。
BMC Med Res Methodol. 2019 Apr 11;19(1):77. doi: 10.1186/s12874-019-0718-8.
8
Assessing the risk of performance and detection bias in Cochrane reviews as a joint domain is less accurate compared to two separate domains.评估 Cochrane 综述中性能和检测偏倚的风险作为一个联合领域不如两个单独领域准确。
BMC Med Res Methodol. 2021 Jul 18;21(1):149. doi: 10.1186/s12874-021-01339-1.
9
Assessing risk of bias judgments for blinding of outcome assessors in Cochrane reviews.评估Cochrane系统评价中结局评估者设盲的偏倚风险判断
J Comp Eff Res. 2020 Jun;9(8):585-593. doi: 10.2217/cer-2019-0181. Epub 2020 May 27.
10
Assessments of attrition bias in Cochrane systematic reviews are highly inconsistent and thus hindering trial comparability.对 Cochrane 系统评价中损耗偏倚的评估高度不一致,从而阻碍了试验之间的可比性。
BMC Med Res Methodol. 2019 Apr 5;19(1):76. doi: 10.1186/s12874-019-0717-9.

引用本文的文献

1
Evidence-b(i)ased practice: Selective and inadequate reporting in early childhood autism intervention research.循证实践:儿童自闭症干预研究中的选择性和不充分报告。
Autism. 2024 Aug;28(8):1889-1901. doi: 10.1177/13623613241231624. Epub 2024 Feb 12.
2
Impact of different nutritional approaches on sarcopenia: a protocol for systematic review and network meta-analysis.不同营养干预措施对肌少症的影响:系统评价和网络荟萃分析方案。
Syst Rev. 2023 Mar 13;12(1):37. doi: 10.1186/s13643-023-02215-3.
3
Differences Between the 2016 and 2022 Editions of the Enhanced Recovery After Bariatric Surgery (ERABS) Guidelines: Call to Action of FAIR Data and the Creation of a Global Consortium of Bariatric Care and Research.
2016 年和 2022 年版减重手术后加速康复(ERABS)指南的差异:呼吁 FAIR 数据和创建全球减重护理与研究联盟。
Obes Surg. 2022 Aug;32(8):2753-2763. doi: 10.1007/s11695-022-06132-7. Epub 2022 Jun 2.
4
Evaluating Reporting Completeness of Patient-Reported Outcomes in Esophageal Motility Disorders: A Cross-Sectional Analysis of Randomized Controlled Trials.评估食管动力障碍患者报告结局的报告完整性:一项随机对照试验的横断面分析。
Dysphagia. 2022 Dec;37(6):1576-1585. doi: 10.1007/s00455-022-10415-7. Epub 2022 Feb 22.
5
Registration and primary outcome reporting in behavioral health trials.行为健康试验的注册和主要结局报告。
BMC Med Res Methodol. 2022 Feb 6;22(1):41. doi: 10.1186/s12874-021-01500-w.
6
Cochrane's risk of bias tool for non-randomized studies (ROBINS-I) is frequently misapplied: A methodological systematic review.Cochrane 的非随机研究偏倚风险工具(ROBINS-I)经常被错误应用:一项方法学系统评价。
J Clin Epidemiol. 2021 Dec;140:22-32. doi: 10.1016/j.jclinepi.2021.08.022. Epub 2021 Aug 23.
7
Assessing the risk of performance and detection bias in Cochrane reviews as a joint domain is less accurate compared to two separate domains.评估 Cochrane 综述中性能和检测偏倚的风险作为一个联合领域不如两个单独领域准确。
BMC Med Res Methodol. 2021 Jul 18;21(1):149. doi: 10.1186/s12874-021-01339-1.
8
Effectiveness of rehabilitation interventions in adults with multi-organ dysfunction syndrome: A rapid review.多器官功能障碍综合征成人康复干预措施的有效性:快速综述。
J Rehabil Med. 2021 Aug 7;53(8):jrm00221. doi: 10.2340/16501977-2846.
9
Relation between COVID-19 and Guillain-Barre syndrome in adults. Systematic review.成人中新型冠状病毒肺炎与吉兰-巴雷综合征的关系。系统评价。
Neurologia (Engl Ed). 2021 Mar;36(2):183-184. doi: 10.1016/j.nrl.2020.10.002. Epub 2020 Oct 12.
10
Adequacy of risk of bias assessment in surgical vs non-surgical trials in Cochrane reviews: a methodological study.Cochrane 综述中手术与非手术试验的偏倚风险评估充分性:一项方法学研究。
BMC Med Res Methodol. 2020 Sep 29;20(1):240. doi: 10.1186/s12874-020-01123-7.